MAP3K7 and breast adenocarcinoma: Mutations in the NOD1/2 signaling pathway and in DNA binding transcription factor activity, affecting genes such as MAP3K7, UBE2N, IKBKG, CHUK, and IKBKB, occurred late in breast adenocarcinoma and ovarian adenocarcinoma (Fig. S7–8).